TY - JOUR
T1 - Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women
AU - Li, Y.
AU - Munger, K. L.
AU - Batool-Anwar, S.
AU - De Vito, K.
AU - Ascherio, A.
AU - Gao, X.
N1 - Funding Information:
Study funding: Supported by NIH/NINDS grants of R01-NS062879-01A2 and NIH grant P01-CA87969 . None of the sponsors participated in the study design, data collection, analysis, or interpretation.
Funding Information:
Dr. Li, Dr. Munger, Dr. Batool-Anwar, and K. De Vito report no disclosures. Dr. Ascherio serves on a scientific advisory board for the Michael J. Fox Foundation; serves on the editorial boards of Neurology®, Annals of Neurology, and the American Journal of Epidemiology; has received speaker honoraria from Merck Serono; and receives research support from the NIH, the US Department of Defense, and the Michael J. Fox Foundation. Dr. Gao has received research support from the NIH/NINDS and reported consultancy relationship with Teva. Go to Neurology.org for full disclosures.
PY - 2012/5/8
Y1 - 2012/5/8
N2 - Objective: To assess the association of multiple sclerosis (MS) with concurrent restless legs syndrome (RLS) and daytime sleepiness. We also prospectively examined whether women with MS had an increased risk of developing RLS during 4 years of follow-up. Methods: The main analysis was based on a cross-sectional study of 65,544 women (aged 41-58 years) free of diabetes, arthritis, and pregnancy, who were participating in the Nurses' Health Study II cohort. Participants were considered to have RLS if they met 4 RLS diagnostic criteria recommended by the International Restless Leg Syndrome Study Group and had restless legs -5 times/month. MS was self-reported and confirmed by medical record review. Results: Among women with MS, the prevalence of RLS and severe RLS (15± times/month) were 15.5% and 9.9% in 2005, respectively, relative to 6.4% and 2.6% among women without MS. After adjustment for potential confounders and the presence of other sleep disorders, women with MS had a higher likelihood of having RLS (odds ratio [OR] = 2.72, 95% confidence interval [CI] 1.89-3.93), severe RLS (OR = 4.12, 95% CI 2.65-6.42), and daily daytime sleepiness (OR = 2.11, 95% CI 1.31-3.42) compared with women without MS. Among the 172 women who had MS and were free of RLS in 2005, 9 developed RLS (5.2%) during a 4-year period and all had severe RLS. The adjusted relative risk of severe RLS was 3.58 (95% CI 1.53-8.35), comparing women with MS at baseline with those without MS. Conclusion: Women with MS had a significantly higher prevalence of RLS and daytime sleepiness and an increased risk of developing RLS in the future.
AB - Objective: To assess the association of multiple sclerosis (MS) with concurrent restless legs syndrome (RLS) and daytime sleepiness. We also prospectively examined whether women with MS had an increased risk of developing RLS during 4 years of follow-up. Methods: The main analysis was based on a cross-sectional study of 65,544 women (aged 41-58 years) free of diabetes, arthritis, and pregnancy, who were participating in the Nurses' Health Study II cohort. Participants were considered to have RLS if they met 4 RLS diagnostic criteria recommended by the International Restless Leg Syndrome Study Group and had restless legs -5 times/month. MS was self-reported and confirmed by medical record review. Results: Among women with MS, the prevalence of RLS and severe RLS (15± times/month) were 15.5% and 9.9% in 2005, respectively, relative to 6.4% and 2.6% among women without MS. After adjustment for potential confounders and the presence of other sleep disorders, women with MS had a higher likelihood of having RLS (odds ratio [OR] = 2.72, 95% confidence interval [CI] 1.89-3.93), severe RLS (OR = 4.12, 95% CI 2.65-6.42), and daily daytime sleepiness (OR = 2.11, 95% CI 1.31-3.42) compared with women without MS. Among the 172 women who had MS and were free of RLS in 2005, 9 developed RLS (5.2%) during a 4-year period and all had severe RLS. The adjusted relative risk of severe RLS was 3.58 (95% CI 1.53-8.35), comparing women with MS at baseline with those without MS. Conclusion: Women with MS had a significantly higher prevalence of RLS and daytime sleepiness and an increased risk of developing RLS in the future.
UR - http://www.scopus.com/inward/record.url?scp=84863617778&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863617778&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3182553c5b
DO - 10.1212/WNL.0b013e3182553c5b
M3 - Article
C2 - 22539566
AN - SCOPUS:84863617778
SN - 0028-3878
VL - 78
SP - 1500
EP - 1506
JO - Neurology
JF - Neurology
IS - 19
ER -